A type of rodent called the multimammate rat carries the Lassa fever virus in its pee and poop. There are lots of these rats in West, Central, and East Africa. They tend to live in homes and in ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

The UK Health Security Agency has published a list of the 24 pathogen families that could pose the greatest risk to public ...

The viruses that pose the biggest risk to public health have been revealed. Among the viral pathogen families classed as high ...

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

Lassa fever is a viral hemorrhagic disease that can be fatal and that causes permanent hearing loss in up to one-third of those who contract it. Lassa virus is spread by rodents, known as multimammate ...

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a decline in new confirmed Lassa fever cases across ...